How Ph.D. was paid
$10M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| John Quisel, J.D., Ph.D.President and Chief Executive Officer | $695,000 | $4,285,817 | $4,441,046 | $554,263 | $10,500 | $9,986,626 |
| Jean FranchiChief Financial Officer | $531,000 | $1,969,560 | $1,360,603 | $307,980 | — | $4,169,143 |
| Pamela Stephenson, M.P.H.Chief Commercial Officer | $520,000 | $1,969,560 | $1,360,603 | $301,600 | $10,500 | $4,162,263 |
| William Savage, M.D., Ph.D.Chief Medical Officer | $523,000 | $1,313,040 | $1,360,603 | $303,340 | $10,500 | $3,510,483 |
| Jonathan Yu, M.B.A.Chief Operating Officer | $507,000 | $1,313,040 | $1,360,603 | $294,060 | $10,500 | $3,485,203 |
What changed and why
- $10MCEO total compensation increased to $9,986,626 in 2025 compared to $9,065,924 in 2024.
- Stock and option awards represented the largest components of executive compensation.
- 99.24%At the 2025 annual meeting, the say-on-pay proposal received 99.24% support from stockholders.
- Global employee population consisted of 154 individuals excluding the CEO for pay ratio purposes.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.